Leukemia Cell Cultures for Research of New Anti-Cancer Therapies
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Oct 9, 2009
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with suspected de novo or secondary or relapsed acute leukemia, requiring complementary blood test and bone marrow analysis
- • Patients older or equal than 28 days
- • Informed consent signed
- Exclusion Criteria:
- • Pregnancy
- • Breastfeeding
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Strasbourg, , France
Patients applied
Trial Officials
Raoul Herbrecht, MD
Principal Investigator
Département d'Hématologie et d'Oncologie-hôpital de Hautepierre Strasbourg, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials